Nephrocare Health Services Ltd
Incorporated in 2010, Nephrocare Health Services Ltd. provides end-to-end dialysis care through a wide network of clinics across India and select international markets.[1]
- Market Cap ₹ 4,615 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 69.4
- Book Value ₹
- Dividend Yield %
- ROCE 14.1 %
- ROE 13.4 %
- Face Value ₹ 2.00
Pros
- Company's working capital requirements have reduced from 33.7 days to 26.7 days
Cons
- Company has a low return on equity of 7.01% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 318 | 437 | 566 | 756 | |
| 301 | 389 | 465 | 589 | |
| Operating Profit | 17 | 49 | 101 | 167 |
| OPM % | 5% | 11% | 18% | 22% |
| 10 | 6 | 8 | 14 | |
| Interest | 11 | 16 | 20 | 21 |
| Depreciation | 42 | 47 | 56 | 72 |
| Profit before tax | -27 | -9 | 33 | 87 |
| Tax % | -21% | 37% | -6% | 23% |
| -21 | -12 | 35 | 67 | |
| EPS in Rs | -106.93 | -58.69 | 169.82 | 321.87 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| TTM: | 34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 72% |
| TTM: | 89% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 7% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 |
| Reserves | 391 | 384 | 409 | 579 |
| 119 | 200 | 271 | 261 | |
| 60 | 81 | 124 | 153 | |
| Total Liabilities | 571 | 666 | 806 | 994 |
| 206 | 239 | 356 | 396 | |
| CWIP | 27 | 34 | 1 | 6 |
| Investments | 0 | 0 | 0 | 51 |
| 338 | 393 | 449 | 542 | |
| Total Assets | 571 | 666 | 806 | 994 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 14 | 11 | 72 | 135 | |
| -130 | -76 | -52 | -125 | |
| 121 | 60 | 27 | 54 | |
| Net Cash Flow | 6 | -4 | 47 | 65 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 123 | 132 | 131 | 129 |
| Inventory Days | 50 | 67 | ||
| Days Payable | 70 | 63 | ||
| Cash Conversion Cycle | 103 | 137 | 131 | 129 |
| Working Capital Days | 54 | 19 | 56 | 27 |
| ROCE % | 1% | 8% | 14% |
Documents
Annual reports
No data available.
Business Profile[1]
Nephrocare Health Services Limited (NHSL) is India’s largest dialysis-care provider offering a full spectrum of renal-care services haemodialysis, peritoneal dialysis, home haemodialysis, dialysis-on-call, dialysis-on-wheels, pharmacy support, diagnostics, and wellness management. It operates through captive hospital-based clinics, standalone centres, and large Public-Private Partnership (PPP) units.